Skip to Content

Steris PLC

STE: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$326.00GqvfvjjCspqtqfsq

Narrow-Moat Steris Sees Sequential Gains in Fiscal Second Quarter; Shares Still Fairly Priced

Narrow-moat Steris reported improved fiscal 2021 second-quarter results. While revenue and earnings increased compared with the year-ago period, the firm’s growth trajectory continues to be slowed by the ongoing COVID-19 pandemic. We are maintaining our $175 fair value estimate and believe the shares are fairly valued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of STE so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center